JP2022521705A5 - - Google Patents
Info
- Publication number
- JP2022521705A5 JP2022521705A5 JP2021547303A JP2021547303A JP2022521705A5 JP 2022521705 A5 JP2022521705 A5 JP 2022521705A5 JP 2021547303 A JP2021547303 A JP 2021547303A JP 2021547303 A JP2021547303 A JP 2021547303A JP 2022521705 A5 JP2022521705 A5 JP 2022521705A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024229509A JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201941005395 | 2019-02-11 | ||
| IN201941005395 | 2019-02-11 | ||
| PCT/US2020/017518 WO2020167668A1 (en) | 2019-02-11 | 2020-02-10 | Anti-clec2d antibodies and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024229509A Division JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022521705A JP2022521705A (ja) | 2022-04-12 |
| JP2022521705A5 true JP2022521705A5 (https=) | 2023-02-20 |
| JPWO2020167668A5 JPWO2020167668A5 (https=) | 2023-02-20 |
| JP7612591B2 JP7612591B2 (ja) | 2025-01-14 |
Family
ID=69811875
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547303A Active JP7612591B2 (ja) | 2019-02-11 | 2020-02-10 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
| JP2024229509A Pending JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024229509A Pending JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11827710B2 (https=) |
| EP (1) | EP3924385A1 (https=) |
| JP (2) | JP7612591B2 (https=) |
| KR (1) | KR20220007584A (https=) |
| AU (1) | AU2020222891A1 (https=) |
| CA (1) | CA3129818A1 (https=) |
| IL (1) | IL285401A (https=) |
| NZ (1) | NZ778293A (https=) |
| SG (1) | SG11202108403UA (https=) |
| WO (1) | WO2020167668A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220007584A (ko) * | 2019-02-11 | 2022-01-18 | 주무토르 바이오로직스 인코포레이티드 | 항-clec2d 항체 및 이의 사용 방법 |
| CN115443140A (zh) * | 2020-04-02 | 2022-12-06 | 苏州恒康生命科学有限公司 | 人ror-1抗体和抗ror-1-car-t细胞 |
| EP4225795A4 (en) * | 2020-10-05 | 2025-03-26 | Monash University | Clec9a antibodies |
| JPWO2022202985A1 (https=) * | 2021-03-24 | 2022-09-29 | ||
| WO2023039242A2 (en) * | 2021-09-13 | 2023-03-16 | Achelois Biopharma, Inc. | Multivalent interferon particles compositions and methods of use |
| CN114685663B (zh) * | 2022-04-07 | 2023-09-08 | 西南大学 | 一种抗胆固醇依赖性细胞溶素的抗体及其应用 |
| CA3254800A1 (en) * | 2022-05-31 | 2023-12-07 | The Brigham And Women's Hospital, Inc. | Anti-BMP9 antibodies and their methods of use |
| KR20250122456A (ko) * | 2022-11-01 | 2025-08-13 | 프로비던스 헬스 앤드 서비시즈 - 오레곤 | Fas 리간드에 특이적인 단일클론 항체 및 이의 용도 |
| CN115894675B (zh) * | 2023-02-03 | 2023-11-14 | 康复大学(筹) | 新冠病毒SARS-CoV-2核衣壳蛋白单克隆抗体及其应用 |
| WO2024226468A2 (en) * | 2023-04-24 | 2024-10-31 | Elpis Pharmaceuticals | Armored anti-b7h3 car-t cells and uses thereof in cancer therapy |
| WO2025096542A2 (en) * | 2023-10-30 | 2025-05-08 | Immunitas Therapeutics, Inc. | Clec2d binding proteins and related methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| WO1995022618A1 (en) | 1994-02-22 | 1995-08-24 | Dana-Farber Cancer Institute | Nucleic acid delivery system, method of synthesis and uses thereof |
| US7147854B2 (en) | 1997-06-23 | 2006-12-12 | Yes Biotech Laboratories Ltd. | Topical treatment of psoriasis using neutralizing antibodies to interleukin-8 |
| US20040001804A1 (en) * | 1999-12-30 | 2004-01-01 | Mathew Porunelloor A. | LLT uses thereof in immune system modulation |
| US9127052B2 (en) * | 2010-06-29 | 2015-09-08 | Centre National De La Recherche Scientifique | LLT-1 antibodies with new functional properties |
| US9111624B2 (en) | 2013-03-22 | 2015-08-18 | Katsuyuki Fujita | Semiconductor memory device |
| KR20220007584A (ko) * | 2019-02-11 | 2022-01-18 | 주무토르 바이오로직스 인코포레이티드 | 항-clec2d 항체 및 이의 사용 방법 |
-
2020
- 2020-02-10 KR KR1020217029054A patent/KR20220007584A/ko active Pending
- 2020-02-10 EP EP20711372.1A patent/EP3924385A1/en active Pending
- 2020-02-10 JP JP2021547303A patent/JP7612591B2/ja active Active
- 2020-02-10 CA CA3129818A patent/CA3129818A1/en active Pending
- 2020-02-10 SG SG11202108403UA patent/SG11202108403UA/en unknown
- 2020-02-10 WO PCT/US2020/017518 patent/WO2020167668A1/en not_active Ceased
- 2020-02-10 US US16/786,391 patent/US11827710B2/en active Active
- 2020-02-10 NZ NZ778293A patent/NZ778293A/en unknown
- 2020-02-10 AU AU2020222891A patent/AU2020222891A1/en active Pending
-
2021
- 2021-08-05 IL IL285401A patent/IL285401A/en unknown
-
2023
- 2023-05-08 US US18/314,117 patent/US12460007B2/en active Active
-
2024
- 2024-12-25 JP JP2024229509A patent/JP2025062598A/ja active Pending